{{Rsnum
|rsid=12591257
|Gene=AGBL1
|Chromosome=15
|position=86520858
|Orientation=plus
|GMAF=0.03489
|Gene_s=AGBL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 91.1 | 8.9 | 0.0
| HCB | 83.2 | 16.1 | 0.7
| JPT | 92.9 | 7.1 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 83.2 | 16.1 | 0.7
| CHD | 89.9 | 9.2 | 0.9
| GIH | 98.0 | 2.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 98.3 | 1.7 | 0.0
| MKK | 98.7 | 1.3 | 0.0
| TSI | 95.1 | 4.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23594818
  |Trait=Psychosis (methamphetamine induced)
  |Title=Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
  |RiskAllele=A
  |Pval=4E-6
  |OR=5.26
  |ORtxt=[NR]
  }}

{{on chip | Affy GenomeWide 6}}